## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo
Levetiracetam in the treatment of vascular chorea: a case report
✍ Scribed by Marco D’Amelio; Graziella Callari; Matilde Gammino; Valentina Saia; Innocenzo Lupo; Giuseppe Salemi; Paolo Ragonese; Giovanni Savettieri
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 153 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We describe a thyrotoxic patient with choreic movements. The latter gradually receded and disappeared as the patient was treated with methimazole and β‐adrenoceptor blocker, and the improvement deteriorated during a β‐adrenoceptor challenge test. Our findings suggest that the pathogenes
## Abstract We report two first in man cases of percutaneous revascularization for severe intrapopliteal arterial disease using the novel PV atherectomy device. © 2007 Wiley‐Liss, Inc.